Correlation Between Structure Therapeutics and Travere Therapeutics
Can any of the company-specific risk be diversified away by investing in both Structure Therapeutics and Travere Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Structure Therapeutics and Travere Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Structure Therapeutics American and Travere Therapeutics, you can compare the effects of market volatilities on Structure Therapeutics and Travere Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Structure Therapeutics with a short position of Travere Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Structure Therapeutics and Travere Therapeutics.
Diversification Opportunities for Structure Therapeutics and Travere Therapeutics
-0.27 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Structure and Travere is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Structure Therapeutics America and Travere Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Travere Therapeutics and Structure Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Structure Therapeutics American are associated (or correlated) with Travere Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Travere Therapeutics has no effect on the direction of Structure Therapeutics i.e., Structure Therapeutics and Travere Therapeutics go up and down completely randomly.
Pair Corralation between Structure Therapeutics and Travere Therapeutics
Given the investment horizon of 90 days Structure Therapeutics American is expected to under-perform the Travere Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Structure Therapeutics American is 1.04 times less risky than Travere Therapeutics. The stock trades about -0.13 of its potential returns per unit of risk. The Travere Therapeutics is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest 1,456 in Travere Therapeutics on August 25, 2024 and sell it today you would earn a total of 369.00 from holding Travere Therapeutics or generate 25.34% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Structure Therapeutics America vs. Travere Therapeutics
Performance |
| Timeline |
| Structure Therapeutics |
| Travere Therapeutics |
Structure Therapeutics and Travere Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Structure Therapeutics and Travere Therapeutics
The main advantage of trading using opposite Structure Therapeutics and Travere Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Structure Therapeutics position performs unexpectedly, Travere Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Travere Therapeutics will offset losses from the drop in Travere Therapeutics' long position.| Structure Therapeutics vs. Day One Biopharmaceuticals | Structure Therapeutics vs. X4 Pharmaceuticals | Structure Therapeutics vs. Inozyme Pharma | Structure Therapeutics vs. Acumen Pharmaceuticals |
| Travere Therapeutics vs. Eliem Therapeutics | Travere Therapeutics vs. HCW Biologics | Travere Therapeutics vs. Scpharmaceuticals | Travere Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |